The Evolving Therapeutic Paradigm in IBD: Optimal Positioning of New and Emerging Agents
47:55
Evaluating Current and Emerging Targeted Therapies in Hepatocellular Carcinoma
2:06:35
The Nitty Gritty of Fistulizing Crohn's Disease | IBDENC | AIG Hospitals
1:33:13
Unlock Updated Guidelines for the Treatment of RRMM
21:13
Update on vedolizumab in IBD: What have we learned?
7:50
Atezolizumab Stumbles in Triple Negative Breast Cancer Study: SABCS 2024 Results with Charles Geyer
1:53:29
Spondyloarthritis (SpA) and Psoriatic Arthritis (PsA) Treatment Update for Clinicians
1:55:27
Worst Fails of the Year | Try Not to Laugh 💩
1:05:56